Since an increase in follicle stimulating hormone (FSH) is a landmark feature of perimenopause followed by a decrease in estradiol [35,36,37], the increased prevalence of hyperuricemia after menopause indicates that the female sex hormone may have protective effects against hyperuricemia. Here, BRD2 is linked to hyperuricemia.